EUVIMEDEUVIMED entdecken
Crossref

The missing comparator: Why MS drug risks are clear, but MS disease risks are not

Dominic Shadbolt

Advances in Clinical Neuroscience & Rehabilitation · 2026

DOI: 10.47795/akar7136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Clinical Neuroscience & Rehabilitation, 2026. Verfasst von Dominic Shadbolt. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Shadbolt, D. (2026). The missing comparator: Why MS drug risks are clear, but MS disease risks are not. Advances in Clinical Neuroscience & Rehabilitation. https://doi.org/10.47795/akar7136

Vancouver

Shadbolt D. The missing comparator: Why MS drug risks are clear, but MS disease risks are not. Advances in Clinical Neuroscience & Rehabilitation. 2026. doi:10.47795/akar7136

BibTeX
@article{Shadbolt2026,
  author = {Shadbolt, Dominic},
  title = {The missing comparator: Why MS drug risks are clear, but MS disease risks are not},
  journal = {Advances in Clinical Neuroscience & Rehabilitation},
  year = {2026},
  doi = {10.47795/akar7136}
}
Kostenlos starten →